VRDN - Viridian Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$38.13
DETAILS
HIGH:
$50.00
LOW:
$26.00
MEDIAN:
$36.50
CONSENSUS:
$38.13
UPSIDE:
121.17%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -476.6% |
| EBITDA Margin | -475.9% |
| Operating Margin | -512.9% |
| Pretax Margin | -483.6% |
| Cont. Ops Margin | -483.6% |
| Net Margin | -483.6% |
| Bottom Line Margin | -397.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 12.65 |
| Quick Ratio | 12.65 |
| Solvency Ratio | -1.930 |
| Cash Ratio | 3.00 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-7.70
Peers avg: 13.8
|
| PEG Ratio | 0.46 |
| Forward PEG | 0.46 |
| Price/Book | 3.65 |
| Price/Sales | 37.25 |
| Price/FCF | -9.53 |
| Price/Op Cash Flow | -9.55 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0564 |
| Debt/Equity | 0.0702 |
| Debt/Capital | 0.0656 |
| Long-Term Debt/Capital | 0.0647 |
| Financial Leverage | 1.25 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.09 |
| Operating Cash Flow Ratio | -3.910 |
| Operating Cash Flow/Sales | -390.1% |
| Free Cash Flow/Operating Cash Flow | 100.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -59.15 |
| Interest Coverage | -73.4428 |
| Short-Term Operating Cash Flow Coverage | -367.05 |
| Operating Cash Flow Coverage | -5.45 |
| Capital Expenditure Coverage | -558.37 |
| Dividend + Capital Expenditure Coverage | -558.37 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.84 |
| EPS | -4.040 |
| Debt/Share | 0.6561 |
| Cash/Share | 10.31 |
| Book Value/Share | 8.52 |
| Tangible BV/Share | 8.52 |
| Equity/Share | 8.52 |
| Operating Cash Flow/Share | -3.259 |
| Capital Expenditure/Share | 0.006 |
| FCF/Share | -3.265 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.943 |
| Price/Fair Value | 3.65 |
| Debt/Market Cap | 0.0192 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -7.35 |